SEC

Former AstraZeneca exec committed insider trading on landmark 2019 Enhertu deal, SEC alleges
Endpoints
Tue, 05/31/22 - 10:39 am
AstraZeneca
insider trading
SEC
Enhertu
Daiichi Sankyo
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Biogen
earnings
SEC
Eli Lilly
Merck
Bristol Myers Squibb
Pfizer
AbbVie
SEC to propose new rules to rein in SPACs
Endpoints
Wed, 03/30/22 - 11:07 am
SEC
regulatory
SPACs
Baxter hit with $18M SEC penalty for accounting improprieties
Medtech Dive
Fri, 02/25/22 - 09:43 am
devices
Medtech
SEC
Baxter International
Biogen says U.S. FTC, SEC probing Alzheimer's disease drug
Reuters
Mon, 02/7/22 - 11:26 pm
Biogen
Aduhelm
FTC
SEC
Alzheimer's disease
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Fierce Pharma
Tue, 02/1/22 - 11:28 pm
Amgen
Novartis
Aimovig
migraines
SEC
Fore fires CEO Malik after SEC insider trading charges during his time as Immunomedics CFO
Fierce Biotech
Thu, 12/2/21 - 10:58 pm
SEC
insider trading
Immunomedics
Usama Malik
Cassava Sciences under SEC probe for manipulating Alzheimer’s drug data
Seeking Alpha
Wed, 11/17/21 - 10:45 am
Cassava Sciences
SEC
data manipulation
Alzheimer's disease
The SEC Wants Badly Behaved Companies to Admit They Did Wrong
Motley Fool
Wed, 10/13/21 - 10:42 pm
SEC
regulatory
5 years after Pfizer buyout, SEC charges Medivation's ex-dealmaking lead with insider trading
Fierce Pharma
Tue, 08/17/21 - 10:49 pm
Medivation
Pfizer
M&A
SEC
insider trading
CytoDyn catches SEC, DOJ scrutiny over public claims about COVID-19 drug's viability
Fierce Biotech
Tue, 08/3/21 - 11:14 am
CytoDyn
FDA
COVID-19
DOJ
SEC
SPAC listings slow as the hunt for deals continues
EP Vantage
Mon, 07/12/21 - 10:38 am
SPACs
SEC
Health tech SPAC deals on pause
EP Vantage
Fri, 06/11/21 - 10:46 am
SPAC
M&A
SEC
How Five Prime suitor Amgen battled multiple companies for the biotech—and won
Fierce Biotech
Fri, 03/19/21 - 10:48 am
Amgen
M&A
Five Prime Therapeutics
SEC
oncology
SEC charges uBiome co-founders with $60M securities fraud
MedCity News
Thu, 03/18/21 - 08:30 pm
SEC
uBiome
securities fraud
Biotech scandal drags on as the feds only score partial victory against execs charged with cooking the books
Endpoints
Wed, 02/3/21 - 10:44 am
SEC
Osiris Therapeutics
SEC awards $2.5M to Orthofix whistleblowers
Mass Device
Thu, 09/3/20 - 10:09 am
Orthofix
whistleblowers
devices
SEC
FCPA
Poseida shares plunge after death in solid tumor CAR-T trial, clinical hold
Fierce Biotech
Tue, 08/18/20 - 11:05 pm
Poseida Therapeutics
solid tumors
CAR-T
SEC
prostate cancer
Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case
Motley Fool
Mon, 07/6/20 - 10:29 am
Alexion Pharmaceuticals
SEC
bribery
FCPA
Novartis inks settlements worth $347M with DOJ, SEC over foreign doctor payments, records keeping
Fierce Pharma
Thu, 06/25/20 - 08:39 pm
Novartis
DOJ
kickbacks
physicians
FCPA
SEC

Pages